Quantification of succinic acid levels, linked to succinate dehydrogenase (SDH) dysfunctions, by an automated and fully validated liquid chromatography tandem mass spectrometry method suitable for multi-matrix applications
Quantification of succinic acid levels, linked to succinate dehydrogenase (SDH) dysfunctions, by an automated and fully validated liquid chromatography tandem mass spectrometry method suitable for multi-matrix applications
复制标题
DOI:
10.1016/j.jchromb.2021.123085
复制
发表时间:
2022-01-15
影响因子:
3
通讯作者:
Broutin, Sophie
中科院分区:
文献类型:
--
作者:
Lamy, Constance;Mansard, Clemence;Broutin, Sophie
The hallmarks of cancer include metabolism with deregulating cellular energetics. Dysfunctions in succinate dehydrogenase (SDH) metabolic enzyme activity, leading to an abnormal accumulation of succinic acid has been described in solid tumors but also in inflammation and ischemia reperfusion injury. Succinic acid is a potential biomarker of SDH related pathologies for diagnostic, evaluation of treatment response and follow-up of the disease. We developed a liquid chromatography tandem mass spectrometry (LC-MS/MS) method allowing a rapid, accurate and precise quantification of succinic acid levels in clinical (serum, urine) and preclinical (cellular pellets, supernatants) samples. C-13(4) succinic acid disodium salt was used as internal standard and added to samples before a solid phase extraction (SPE) on Phenomenex STRATA (TM) XL-A (200 mg - 3 mL) 33 mu m cartridges. This method is automated by a Freedom EVO (R) platform from TECAN and succinic acid is separated on a C18 column combined to a Xevo (R) TQ-S micro Waters mass spectrometer with electrospray ionization (ESI) source. This biomedical analysis allows standard curves to be linear over the range 1.0-135.5 mu M with r(2) values > 0.999 and low matrix effects (